Alex Clay Hoover MD
Pediatric Hematologic Oncology
Physician
Join to View Full Profile
2450 Riverside AveMinneapolis, MN 55454
Phone+1 612-365-8100
Dr. Hoover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Alex Hoover, MD, is a Minneapolis-based specialist in Pediatric Hematology & Oncology with a subspecialty in Pediatric Hematologic Oncology. He completed his residency in Pediatrics at the University of Iowa Hospitals and Clinics and his fellowship in Pediatric Hematology/Oncology at the University of Minnesota in 2023. Dr. Hoover is currently a Clinical Fellow at M Health Fairview Masonic Children’s Hospital. His publications focus on clinical manifestations of Fanconi anemia, the impact of COVID-19 on pediatric care, and the costs associated with treatments for pediatric acute lymphoblastic leukemia.
Education & Training
M Health FairviewPediatric Hematology & Oncology, 2023
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2023
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 2017 - 2020
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2017
Certifications & Licensure
MN State Medical License 2020 - 2026
IA State Medical License 2017 - 2020
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 4 citationsLongitudinal clinical manifestations of Fanconi anemia: A systematized review.Alex Hoover, Lucie M Turcotte, Rachel Phelan, Crystal Barbus, Arpana Rayannavar
Blood Reviews. 2024-11-01 - Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL.Alex Hoover, Dave Watson, Paige Reimche, Lynn Tanner, Laura Gilchrist
BMC Research Notes. 2024-04-22 - 3 citationsHealthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance c...Alex Hoover, Paige Reimche, Dave Watson, Lynn Tanner, Laura Gilchrist
Cancer Reports. 2024-02-01
Press Mentions
- Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials with Shernan Holtan, MDMarch 8th, 2023
- The Price of Hope: CAR-T Therapy in Pediatric LeukemiaMay 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
